Alnylam Forges Landmark $1.23 Billion Cardiovascular Discovery Alliance with Tenaya Therapeutics to Advance Disease-Modifying Therapies
Alnylam Pharmaceuticals, a leader in RNA interference (RNAi) therapeutics, has entered into a significant discovery...
